Literature DB >> 17124229

Osteonecrosis of the jaw and bisphosphonates: editorial was confusing.

Mark J Bolland, Andrew Grey, Ian R Reid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17124229      PMCID： PMC1661702          DOI： 10.1136/bmj.39037.696759.3A

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors.

Authors:  Tuncay Delibasi; Kadri Altundag; Yesim Kanlioglu
Journal:  J Oral Maxillofac Surg       Date:  2006-06       Impact factor: 1.895

2.  Osteonecrosis of the jaw: more research needed.

Authors:  Elizabeth Shane; Steve Goldring; Sylvia Christakos; Marc Drezner; John Eisman; Stuart Silverman; David Pendrys
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

3.  Osteonecrosis of the jaw after treatment with bisphosphonates: is irreversible, so the focus must be on prevention.

Authors:  Basile Nicolas Landis; Michel Richter; Ivan Dojcinovic; Max Hugentobler
Journal:  BMJ       Date:  2006-11-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.